Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Incyte Corporation
Nicholas Gueguen
| Jul 23, 2017
Incyte, Merck to conduct tests on epacadostat and Keytruda combination treatment
Nicholas Gueguen
| Jul 20, 2017
Bristol-Myers Squibb, Incyte begin registrational trials of Opdivo-epacadostat combo therapy for treating two types of cancer
Trending
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 25, 2024
"My Future Depends on It:" Local Teacher Raises Nearly $95,000 for Lung Cancer Research
+
Pharmaceuticals
Patient Daily
| Apr 25, 2024
Labor and delivery nurse overcomes cancer and heart failure
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial